Lactobacillus reuteri Maintains a Functional Mucosal Barrier during DSS Treatment Despite Mucus Layer Dysfunction

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Dicksved, Johan ^a   Schreiber, Olof ^b   Willing, Ben ^a,c   Petersson, Joel ^b   Rang, Sara ^b,d   Phillipson, Mia ^b   Holm, Lena ^b   Roos, Stefan ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE;

ACINETOBACTER; ACINETOBACTER JOHNSONII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; BIFIDOBACTERIUM ANIMALIS; CLOSTRIDIALES; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DNA ISOLATION; FIRMICUTES; LACTOBACILLALES; LACTOBACILLUS REUTERI; MALE; MESENTERY LYMPH NODE; MICROBIAL COMMUNITY; MICROFLORA; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEOBACTERIA; RAT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANIMALS; BACTERIAL LOAD; BACTERIAL TRANSLOCATION; COLITIS; COLON; DEXTRAN SULFATE; INTESTINAL MUCOSA; LACTOBACILLUS REUTERI; MALE; METAGENOME; MUCUS; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; RNA, RIBOSOMAL, 16S;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS REUTERI; RATTUS;

EID: 84866914800     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046399     Document Type: Article

References (27)

1. Packey CD, Sartor RB, (2009) Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 22: 292-301.
2. Atuma C, Strugala V, Allen A, Holm L, (2001) The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 280: G922-929.
3. Petersson J, Schreiber O, Hansson GC, Gendler SJ, Velcich A, et al. (2011) Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 300: G327-333.
4. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, et al. (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 105: 15064-15069.
5. Jager S, Stange EF, Wehkamp J, (2010) Antimicrobial peptides in gastrointestinal inflammation. Int J Inflam 2010: 910283.
6. Marchiando AM, Graham WV, Turner JR, (2010) Epithelial barriers in homeostasis and disease. Annu Rev Pathol 5: 119-144.
7. Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, et al. (2007) Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME journal 1: 403-418.
8. Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, et al. (2008) Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J 2: 716-727.
9. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ, (2006) Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 44: 4136-4141.
10. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, et al. (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52: 237-242.
11. Willing B, Dicksved J, Halfvarson J, Andersson A, Lucio M, et al. (2010) A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139: 1844-1854.
12. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Järnerot G, et al. (2009) Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 15: 653-660.
13. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780-13785.
14. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, et al. (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211.
15. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
16. Tamboli CP, Neut C, Desreumaux P, Colombel JF, (2004) Dysbiosis in inflammatory bowel disease. Gut 53: 1-4.
17. Schreiber O, Petersson J, Phillipson M, Perry M, Roos S, et al. (2009) Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions. Am J Physiol Gastrointest Liver Physiol 296: G534-542.
18. Cooper HS, Murthy SN, Shah RS, Sedergran DJ, (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249.
19. Benjamini Y, Hochberg Y, (1995) Controling the false discovery rate: a practical and powerful approach to multiple testing. JR Stat Soc Series B Methodol 57: 289-300.
20. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, et al. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2: 204.
21. Lamine F, Eutamene H, Fioramonti J, Bueno L, Theodorou V, (2004) Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats. Scand J Gastroenterol 39: 1250-1258.
22. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, et al. (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115: 1405-1413.
23. Ye J, Lee JW, Presley LL, Bent E, Wei B, et al. (2008) Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice. Inflamm Bowel Dis 14: 1041-1050.
24. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G, (2009) Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 15: 100-113.
25. Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, et al. (2009) Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296: G1140-1149.
26. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA, (2003) Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52: 827-833.
27. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA, (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276: G941-950.